Skip to content
The Nexus
HEALTHJun 28 · 14:00 UTCTHE HILLFred Roeder, opinion contributor

Dr. Oz’s GLP-1 Bridge could work, but it isn’t a model for price controls

Dr. Oz’s GLP-1 Bridge may be effective but is not a viable model for price controls. The article warns that consumer discounts today could hinder future medical advancements.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting